Medical News

RSS
ImmunID announces publication of clinical study data on ImmunTraCkeR assay in the Journal for ImmunoTherapy of Cancer

ImmunID announces publication of clinical study data on ImmunTraCkeR assay in the Journal for ImmunoTherapy of Cancer

First-of-its-kind 'Transitional Care' provider starts treating Medicare patients

First-of-its-kind 'Transitional Care' provider starts treating Medicare patients

Amedica receives FDA feedback on proposed wear testing femoral head protocols

Amedica receives FDA feedback on proposed wear testing femoral head protocols

Avita Medical donates ReCell devices, sends experienced personnel to help treat burn victims in Taiwan

Avita Medical donates ReCell devices, sends experienced personnel to help treat burn victims in Taiwan

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Free, online resource introduced for patients and healthcare professionals in Canada

Free, online resource introduced for patients and healthcare professionals in Canada

Study aims to determine utility of Trovagene's PCM technology for predicting response to cancer immunotherapy

Study aims to determine utility of Trovagene's PCM technology for predicting response to cancer immunotherapy

Experts argue that 'beyond aid' policies in health care need greater scrutiny

Experts argue that 'beyond aid' policies in health care need greater scrutiny

Resverlogix and Hepalink close license agreement, sign definitive stock purchase agreement

Resverlogix and Hepalink close license agreement, sign definitive stock purchase agreement

Aridis expands, accelerates current AR-301 Phase 2a study for treatment of acute pneumonia in the U.S.

Aridis expands, accelerates current AR-301 Phase 2a study for treatment of acute pneumonia in the U.S.

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

SCIO Health Analytics included in 20 Most Promising Healthcare Analytics Solution Providers list

SCIO Health Analytics included in 20 Most Promising Healthcare Analytics Solution Providers list

OBP Medical introduces CLEAR-TRAC family of disposable surgical retractors

OBP Medical introduces CLEAR-TRAC family of disposable surgical retractors

SISSA scientists create synthetic enzymes that can differentiate between active and inactive genes

SISSA scientists create synthetic enzymes that can differentiate between active and inactive genes

Evidence-based initiative aims to prevent avoidable hospital readmissions

Evidence-based initiative aims to prevent avoidable hospital readmissions

Modified, healthier meal plan for youth with type 1 diabetes more expensive

Modified, healthier meal plan for youth with type 1 diabetes more expensive

City of Hope offers islet cell transplant program to cure type 1 diabetes

City of Hope offers islet cell transplant program to cure type 1 diabetes

Exercise program for older adults with osteoarthritis may soon be covered by Medicare

Exercise program for older adults with osteoarthritis may soon be covered by Medicare

Adolescents more likely to try e-cigarettes when exposed to TV ads

Adolescents more likely to try e-cigarettes when exposed to TV ads

New research shows that pupil response can predict child's risk of depression

New research shows that pupil response can predict child's risk of depression

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.